P-196: In-class transition (iCT) from bortezomib (V)-based induction to oral ixazomib-lenalidomidedexamethasone vs parenteral V-based therapy: comparative effectiveness in newly diagnosed multiple myeloma
Title:
P-196: In-class transition (iCT) from bortezomib (V)-based induction to oral ixazomib-lenalidomidedexamethasone vs parenteral V-based therapy: comparative effectiveness in newly diagnosed multiple myeloma
Author:
Costello, Caitlin Birhiray, Ruemu Kambhampati, Suman Richter, Joshua Abonour, Rafat Lee, Hans Kim, Yong Jin Ren, Kaili Stull, Dawn Marie Cherepanov, Dasha Bogard, Kimberly Noga, Stephen Girnius, Saulius Rifkin, Robert